Press release
October 9, 2026
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV a
Arcutis Biotherapeutics, Inc. (ARQT)
We couldn't retrieve the full text for this release. Read it on the company's site.